Tetrahydropyrrolopyrimidinone compounds and their pharmaceutical uses

TW202641543APending Publication Date: 2026-10-16SHIONOGI & CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114137448
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-24
Filing Date
2025-09-29
Publication Date
2026-10-16
Patent Text Reader

Abstract

The present invention relates to a compound having RIPK1 inhibitory activity. The present invention provides a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art